G. Lauer and B. Walker, Hepatitis C Virus Infection, New England Journal of Medicine, vol.345, issue.1, pp.41-52, 2001.
DOI : 10.1056/NEJM200107053450107

A. Tai and R. Chung, Treatment failure in hepatitis C: Mechanisms of non-response, Journal of Hepatology, vol.50, issue.2, pp.412-432, 2009.
DOI : 10.1016/j.jhep.2008.11.010

C. Hezode, N. Forestier, G. Dusheiko, P. Ferenci, S. Pol et al., Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection, New England Journal of Medicine, vol.360, issue.18, pp.1839-50, 2009.
DOI : 10.1056/NEJMoa0807650

URL : https://hal.archives-ouvertes.fr/inserm-00385235

R. Brown, Hepatitis C and liver transplantation, Nature, vol.77, issue.7053, pp.973-981, 2005.
DOI : 10.1053/jlts.2003.50268

A. Pereira and I. Jacobson, New and experimental therapies for HCV, Nature Reviews Gastroenterology & Hepatology, vol.48, issue.7, pp.403-414, 2009.
DOI : 10.1038/nrgastro.2009.92

J. Timpe and J. Mckeating, Hepatitis C virus entry: possible targets for therapy, Gut, vol.57, issue.12, pp.1728-1765, 2008.
DOI : 10.1136/gut.2007.141630

URL : http://gut.bmj.com/cgi/content/short/57/12/1728

M. Zeisel, F. Cosset, and T. Baumert, Host neutralizing responses and pathogenesis of hepatitis C virus infection, Hepatology, vol.5, issue.1, pp.299-307, 2008.
DOI : 10.1002/hep.22307

URL : https://hal.archives-ouvertes.fr/inserm-00395783

W. Osburn, B. Fisher, K. Dowd, G. Urban, L. Liu et al., Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection, Gastroenterology, vol.138, issue.1, pp.315-324, 2009.
DOI : 10.1053/j.gastro.2009.09.017

J. Pestka, M. Zeisel, E. Blaser, P. Schurmann, B. Bartosch et al., Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences, vol.104, issue.14, pp.6025-6055, 2007.
DOI : 10.1073/pnas.0607026104

URL : https://hal.archives-ouvertes.fr/inserm-00395910

R. 1. Krieger, S. Zeisel, M. Davis, and C. , Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-Claudin-1 associations, Hepatology, vol.79, issue.4, pp.1144-57, 2010.
DOI : 10.1002/hep.23445

URL : https://hal.archives-ouvertes.fr/inserm-00705657

V. Castet, C. Fournier, and A. Soulier, Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro, Journal of Virology, vol.76, issue.16, pp.8189-99, 2002.
DOI : 10.1128/JVI.76.16.8189-8199.2002

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC155162

R. Engle, R. Russell, and R. Purcell, Development of a TaqMan assay for the six major genotypes of hepatitis C virus: Comparison with commercial assays, Journal of Medical Virology, vol.102, issue.1, pp.72-81, 2008.
DOI : 10.1002/jmv.21043

S. Molina, V. Castet, and L. Pichard-garcia, Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent, Journal of Virology, vol.82, issue.1, p.15
DOI : 10.1128/JVI.01443-07

URL : https://hal.archives-ouvertes.fr/inserm-00374410

H. Harris, C. Davis, and J. Mullins, Claudin Association with CD81 Defines Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.285, issue.27, 2010.
DOI : 10.1074/jbc.M110.104836

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898367